We know, from our previous studies that VIP increases the bacterial passage in the human Peyer’s patches [39] and that the bacterial passage is increased in Peyer’s patches of CD patients compared to non-IBD controls [13,40]. This evidence concerns the gene VIP and inflammatory bowel disease.